211 related articles for article (PubMed ID: 30020964)
1. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy.
Stringer EM; Kendall MA; Lockman S; Campbell TB; Nielsen-Saines K; Sawe F; Cu-Uvin S; Wu X; Currier JS
PLoS One; 2018; 13(7):e0199555. PubMed ID: 30020964
[TBL] [Abstract][Full Text] [Related]
2. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV.
Conroy AL; McDonald CR; Gamble JL; Olwoch P; Natureeba P; Cohan D; Kamya MR; Havlir DV; Dorsey G; Kain KC
Am J Obstet Gynecol; 2017 Dec; 217(6):684.e1-684.e17. PubMed ID: 29031892
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia.
Liu KC; Farahani M; Mashamba T; Mawela M; Joseph J; Van Schaik N; Honey E; Gill M; Jassat W; Stringer EM; Chintu N; Marlink RG
AIDS; 2014 Sep; 28(15):2259-68. PubMed ID: 25115319
[TBL] [Abstract][Full Text] [Related]
4. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
BJOG; 2016 May; 123(6):910-6. PubMed ID: 26269220
[TBL] [Abstract][Full Text] [Related]
5. Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
Masaba R; Borkowf CB; Girde S; Zeh C; Ndivo R; Nyang'au I; Achola K; Thomas TK; Lecher SL
AIDS; 2018 Jul; 32(12):1625-1632. PubMed ID: 30001243
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study.
Ejigu Y; Magnus JH; Sundby J; Magnus MC
BMJ Open; 2019 Aug; 9(8):e027344. PubMed ID: 31383698
[TBL] [Abstract][Full Text] [Related]
7. Effects of Antiretroviral Therapy and HIV Exposure in Utero on Adverse Pregnancy and Infant Outcomes: A Prospective Cohort Study in Guangzhou, China.
Hu F; Liang JJ; Lu JJ; Hu YF; Hu Y; Yu J; Zou XW; Ma YH; Lin SF
Biomed Environ Sci; 2019 Oct; 32(10):719-729. PubMed ID: 31843042
[TBL] [Abstract][Full Text] [Related]
8. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Petlo C; Lockman S; Makhema J; Shapiro RL
JAMA Pediatr; 2017 Oct; 171(10):e172222. PubMed ID: 28783807
[TBL] [Abstract][Full Text] [Related]
9. Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):359-64. PubMed ID: 25469525
[TBL] [Abstract][Full Text] [Related]
10. Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland.
Tookey PA; Thorne C; van Wyk J; Norton M
BMC Infect Dis; 2016 Feb; 16():65. PubMed ID: 26847625
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
[TBL] [Abstract][Full Text] [Related]
12. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
[TBL] [Abstract][Full Text] [Related]
13. PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.
Chagomerana MB; Miller WC; Pence BW; Hosseinipour MC; Hoffman IF; Flick RJ; Tweya H; Mumba S; Chimbwandira F; Powers KA
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):367-374. PubMed ID: 27875363
[TBL] [Abstract][Full Text] [Related]
14. Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative Women.
Tukei VJ; Hoffman HJ; Greenberg L; Thabelo R; Nchephe M; Mots'oane T; Masitha M; Chabela M; Mokone M; Mofenson L; Guay L; Tiam A
Pediatr Infect Dis J; 2021 Sep; 40(9):821-826. PubMed ID: 33990522
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
16. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis.
Saint-Lary L; Benevent J; Damase-Michel C; Vayssière C; Leroy V; Sommet A
BMC Pregnancy Childbirth; 2023 Jan; 23(1):80. PubMed ID: 36717801
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study.
Zash R; Jacobson DL; Diseko M; Mayondi G; Mmalane M; Essex M; Gaolethe T; Petlo C; Lockman S; Holmes LB; Makhema J; Shapiro RL
Lancet Glob Health; 2018 Jul; 6(7):e804-e810. PubMed ID: 29880310
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence and associated risk factors on preterm birth, low birth weight, and small for gestational age among HIV-infected pregnant women in Hunan province, 2011-2017].
Li HX; Zheng JF; Huang GW; Xiao J; Wang H; Yang M; Feng N
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Oct; 39(10):1368-1374. PubMed ID: 30453439
[No Abstract] [Full Text] [Related]
20. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
